BLOODPAC Events

BLOODPAC organizes and takes part in events that amplify the promise of liquid biopsy science. As an organization we leverage our collaborative infrastructure to bring together stakeholders in public, industry, academia and regulatory agencies to discuss the most vital issues affecting the liquid biopsy space.

Upcoming Events

Featured Events

  • Beyond the Noise: CHIP in Liquid Biopsy & Clinical Care

    In this virtual seminar, leading experts from academia and industry presented their work on a broad range of CHIP research.

    LEARN MORE

  • BLOODPAC Summit 2022

    Five years after the launch of BLOODPAC, members came together to reflect on our journey and discuss the goals we’ve set for our next chapter.

    EXPERIENCE THE SUMMIT

Past Events

Featured
Panel: Rethinking risk and risk assessment for liquid biopsy-based single and multi-cancer screening
Apr 6
Panel: Rethinking risk and risk assessment for liquid biopsy-based single and multi-cancer screening
Panel: Emerging Approaches to Clinical Validation of MCED Liquid Biopsy Tests
Mar 28
Panel: Emerging Approaches to Clinical Validation of MCED Liquid Biopsy Tests
Talk: Creating consensus on a lexicon for cancer early detection and screening liquid biopsy tests
Mar 28
Talk: Creating consensus on a lexicon for cancer early detection and screening liquid biopsy tests
Panel Discussion: Creating Awareness Amongst Decision-Makers on Local & Global Disparities in Liquid Biopsy Research and Practice to Shape an Inclusive Future for Understudied Diseases
Feb 29
Panel Discussion: Creating Awareness Amongst Decision-Makers on Local & Global Disparities in Liquid Biopsy Research and Practice to Shape an Inclusive Future for Understudied Diseases
Harnessing Liquid Biopsies to Transform Cancer Treatment Selection, Monitoring & Early Detection and Empower Precision Treatments
Feb 29
Harnessing Liquid Biopsies to Transform Cancer Treatment Selection, Monitoring & Early Detection and Empower Precision Treatments
BLOODPAC Q1 2024 Meeting
Feb 13
BLOODPAC Q1 2024 Meeting
Talk: Developing standards to overcome challenges and demonstrate the clinical utility of liquid biopsies in cancer care
Jan 25
Talk: Developing standards to overcome challenges and demonstrate the clinical utility of liquid biopsies in cancer care
Moving Towards Global Harmonization of Liquid Biopsy Frameworks and Standards: The BLOODPAC Experience
Nov 20
Moving Towards Global Harmonization of Liquid Biopsy Frameworks and Standards: The BLOODPAC Experience
Panel Discussion: Creating Consensus on Lexicons, Standards & Frameworks for MCED and MRD Tests for Community Benefit
Nov 8
Panel Discussion: Creating Consensus on Lexicons, Standards & Frameworks for MCED and MRD Tests for Community Benefit
Navigating a Path to Advance the Use of Liquid Biopsies for Early Cancer Screening and Detection (Panel Discussion)
Oct 4
Navigating a Path to Advance the Use of Liquid Biopsies for Early Cancer Screening and Detection (Panel Discussion)
Moving Towards Global Harmonization of Liquid Biopsy Frameworks and Standards: The BLOODPAC Experience (Talk)
Sep 22
Moving Towards Global Harmonization of Liquid Biopsy Frameworks and Standards: The BLOODPAC Experience (Talk)
Creating Consensus on a Lexicon, Standards, and Frameworks for Multi-Cancer Detection (Talk)
Aug 22
Creating Consensus on a Lexicon, Standards, and Frameworks for Multi-Cancer Detection (Talk)
Fireside Chat: Collaborating to Lay the Groundwork for Molecular Residual Disease as an Early Endpoint in Solid Tumors
Aug 22
Fireside Chat: Collaborating to Lay the Groundwork for Molecular Residual Disease as an Early Endpoint in Solid Tumors
Molecular Residual Disease Testing: Confidence and Consistency in MRD assays
Jun 27
Molecular Residual Disease Testing: Confidence and Consistency in MRD assays
Panel Discussion on ctDNA for Solid Tumor Drug Development
Apr 18
Panel Discussion on ctDNA for Solid Tumor Drug Development
BLOODPAC Q1 Meeting 2023
Mar 30
BLOODPAC Q1 Meeting 2023
Strategic Collaboration: Reaching Molecular Residual Disease as an Early Endpoint for Solid Tumors (Panel Discussion)
Mar 6
Strategic Collaboration: Reaching Molecular Residual Disease as an Early Endpoint for Solid Tumors (Panel Discussion)
Standardizing Frameworks and Democratizing Access to Liquid Biopsy (Talk)
Feb 16
Standardizing Frameworks and Democratizing Access to Liquid Biopsy (Talk)
Focused Ultrasound and Liquid Biopsy - 2022 Symposium
Oct 23
Focused Ultrasound and Liquid Biopsy - 2022 Symposium

Hosted by The Focused Ultrasound Foundation

Gen3 Community Forum 2022
Oct 10
Gen3 Community Forum 2022

The University of Chicago and the Australian BioCommons.